You are here

  • Home
  • Archive
  • Volume 97, Issue 12
  • Endophthalmitis following intravitreal anti-VEGF injections in ambulatory surgical centre facility: incidence, management and outcome

Article Text

Article menu
Download PDFPDF
PostScript
Letters
Endophthalmitis following intravitreal anti-VEGF injections in ambulatory surgical centre facility: incidence, management and outcome

https://doi.org/10.1136/bjophthalmol-2013-303222

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Competing interests SJ is an advising committee member of Ozurdex for Allergan. TD is on the advisory boards of Novartis, Alcon and Allergan.

    • Ethics approval Hyderabad Eye Research, Ethics Committee, L V Prasad Eye Institute.

    • Provenance and peer review Not commissioned; externally peer reviewed.

    • Data sharing statement The first and only submission of this data was submitted to BJO. Previously, it had been presented at the ISO-HK conference in Hong Kong in December 2012, and at the AIOS-2013 in Hyderabad, India, in January 2013.